Caricamento...
Emerging FMS-like tyrosine kinase 3 inhibitors for the treatment of acute myelogenous leukemia
INTRODUCTION: The FMS-like tyrosine kinase 3 (FLT3) is highly expressed in acute leukemias. Mutations involving FLT3 are among the most common molecular abnormalities in acute myelogenous leukemia (AML). Available evidence suggests that these molecular lesions confer a shorter disease-free survival...
Salvato in:
| Autori principali: | , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2011
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4122233/ https://ncbi.nlm.nih.gov/pubmed/21417961 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/14728214.2011.568938 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|